HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses.

MLA

Ming-Lung Yu, et al. “HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses.” Journal of Infectious Diseases, vol. 202, no. 1, July 2010, pp. 86–92. EBSCOhost, https://doi.org/10.1086/653209.

APA

Ming-Lung Yu, Chuan-Mo Lee, Wan-Long Chuang, Sheng-Nan Lu, Chia-Yen Dai, Jee-Fu Huang, Zu-Yau Lin, Tsung-Hui Hu, Chien-Hung Chen, Chao-Hung Hung, Jin-Houng Wang, Chi-Ling Chen, Jia-Horng Kao, Ming-Yang Lai, Chen-Hua Liu, Tung-Hung Su, Shun-Sheng Wu, Li-Ying Liao, Hsing-Tao Kuo, & You-Chen Chao. (2010). HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses. Journal of Infectious Diseases, 202(1), 86–92. https://doi.org/10.1086/653209

Chicago

Ming-Lung Yu, Chuan-Mo Lee, Wan-Long Chuang, Sheng-Nan Lu, Chia-Yen Dai, Jee-Fu Huang, Zu-Yau Lin, et al. 2010. “HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses.” Journal of Infectious Diseases 202 (1): 86–92. doi:10.1086/653209.